Molecular surveillance to monitor the prevalence of tetracycline resistance in Neisseria gonorrhoeae

Doxycycline post-exposure prophylaxis (Doxy-PEP) reduces bacterial sexually transmitted infections (STIs) but may select for tetracycline resistance in Neisseria gonorrhoeae and co-resistance to other antibiotics, including ceftriaxone.. The implementation of doxy-PEP should be accompanied by monitoring doxycycline resistance, but the optimal strategy to detect changes in the prevalence of resistance has not been established. We used a deterministic compartmental model of gonorrhea transmission to evaluate the performance of two strategies in providing early warning signals for rising resistance: (1) phenotypic testing of cultured isolates and (2) PCR for tetM in remnants from positive Nucleic Acid Amplification Tests (NAATs) used for gonorrhea diagnosis. For each strategy, we calculated the resistance proportion with 90% simulation intervals as well as the time under each sampling strategy to achieve 95% confidence that the resistance proportion exceeded a resistance threshold ranging from 11–30%. Given the substantially larger available sample size, PCR for tetM in remnant NAATs detected increased high-level tetracycline resistance with high confidence faster than phenotypic testing of cultured specimens. Our results suggest that population surveillance using molecular testing for tetM can complement culturebased surveillance of tetracycline resistance in N. gonorrhoeae and inform policy considerations for doxy-PEP.

Using a deterministic compartmental model of gonorrhea (3), we simulated the transmission of tetracycline-resistant, ceftriaxone-resistant, dual resistant, and fully susceptible gonorrhea strains in a population of 1 million men who have sex with men (MSM), stratified by partner change rates into high, medium, and low risk groups.The initial prevalence of high-level tetracycline was 10.4%, consistent with reported levels in the US (4).The model considered doxy-PEP uptake rates of 10-90% and accounted for treatment with ceftriaxone in response to symptomatic care seeking and asymptomatic screening.In this model, infections initially dropped after rollout of doxy-PEP, followed by a rise in incidence due to selection for tetracycline-resistant strains.Higher doxy-PEP uptake led to not only a steeper initial decline in cases but also faster spread of resistance and therefore a faster uptick in cases after the initial dip (3).Model structure, equations, and parameters are listed below (Figure S1, Table S1).Further details are provided in Reichert and Grad (2023) (3).
We expanded this model to compare the ability to detect increases in tetracycline resistance in two approaches: (1) phenotypic testing of cultured isolates and (2) PCR for tetM in remnants from NAATs.
For phenotypic surveillance, we sampled 25 monthly cultured specimens from all symptomatic urethral cases presenting for care, consistent with the levels monitored as part of GISP.For molecular surveillance, we sampled 20% of positive NAATs, regardless of symptom status.In sensitivity analyses, we considered sampling intensities of 5-80 monthly cultured specimens and 5-80% of positive NAATs.Sampling was simulated as a binomial process with 1000 iterations.
For each simulation, we calculated the proportion of samples that were tetracycline resistant at each sampling time point.Cultured specimens were tested monthly.NAATs were sampled daily and pooled to generate monthly resistance proportion estimates.
We then calculated the mean tetracycline resistance proportion and 90% simulation intervals across all simulations.We compared these estimates with the true resistance proportion of all infections in the population.The primary study outcome was the time it would take under each sampling strategy to be 95% confident that the resistance proportion exceeded a resistance threshold ranging from 11-30%.

Limitations
The model in this study accounted for the key differences between molecular and culturebased surveillance but took a simplified perspective of surveillance overall.For example, we assumed population-wide random sampling for both strategies.Non-random sampling -for example, due to geographic and socioeconomic differences in care seeking behavior or clinics' capacity -may bias the population captured by surveillance efforts under both strategies.Given the additional effort involved in collecting and submitting cultured isolates, we expect the bias to be stronger for culture-based surveillance.NAATs are the clinical standard of care for gonorrhea diagnosis, and they are performed in much higher volume than gonorrhea culture.We also did not explicitly account for lab processing times under different surveillance methods, as these are highly context-dependent.
Our model considered high-level tetracycline resistance conferred by tetM.While it is expected that tetM also confers doxycycline resistance, the relationship between tetracycline and doxycycline resistance in the context of doxy-PEP is not yet fully understood.Prior studies of minocycline pre-exposure prophylaxis have shown failure at a tetracycline MIC > 2 ug/mL (5).Culture-based surveillance can identify low-level tetracycline resistance in strains without tetM (minimum inhibitory concentrations 2-8 µg/mL) in addition to high-level tetracycline resistance driven by tetM.In the US, tetM is present in about 10% of all isolates and about a third of tetracycline-resistant isolates (4).However, it is noteworthy that in some locations, tetM has been detected in up to 100% of all N. gonorrhoeae isolates (6).While assessing for the presence of tetM in remnant NAATs will not capture all instances of tetracycline resistance, tetM remains a critically important resistance indicator that may become more prevalent with widespread use of doxy-PEP.

Figure S2. Delay in 95% confident estimate of rising resistance for varying doxy-PEP uptake levels
Distributions (25 th percentile, median, and 75 th percentile) of the time delay until attaining 95% confidence in crossing a resistance threshold ranging from 0.11 to 0.3 relative to the true time it takes for the resistance to reach the threshold, for doxy-PEP uptake rates ranging from 10-90% (shades of pink), comparing culture-based and NAATs-based surveillance with sampling intensities of 25 monthly cultured specimens and 20% of positive NAATs, respectively.